<DOC>
	<DOC>NCT00482300</DOC>
	<brief_summary>The purpose of this trial is to determine whether the addition of systematic pelvic lymphadenectomy to hysterectomy with bilateral adnexectomy improves disease-free survival (DFS) and overall survival (OS) in patients with preoperatively supposed Stage I-II endometrial cancer</brief_summary>
	<brief_title>Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Histologically proven endometrioid or adenosquamous endometrial carcinoma. Patients having myometrial invasion Age =/&lt; 75 years Informed consent. Serous papillary and clear cell tumors. Karnofsky index &lt; 80 or severe diseases contraindicating surgery Concomitant neoplasia (basalioma cutis excluded) Distant metastasis or abdominal metastasis detected intraoperatively. Absence of myometrial invasion at frozen section.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Histologically proved endometrial carcinoma preoperatively supposed stage I-II</keyword>
</DOC>